Poltreg (WAR:PTG) Valuation Rank


WAR:PTG Poltreg SA WAR:PTG
46 GF Score
Price zł19.15
GF Value zł14.20
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Poltreg Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Poltreg Valuation Rank Related Terms

WAR:PTG
46GF Score
Poltreg SA WAR:PTG
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Poltreg (WAR:PTG) Overvalued in 2026?

Based on GuruFocus' analysis, Poltreg stock appears to be overvalued. The current stock price of zł19.15 is trading 34.9% above its estimated GF Value™ of zł14.20. GuruFocus considers Poltreg to be Significantly Overvalued.

Key valuation signals for WAR:PTG:

  • Valuation Rank:
  • GF Value™: zł14.20 vs. price of zł19.15 (34.9% above fair value)
  • GF Score™: 46/100 with 2 warning signs

No single metric tells the full story. See the WAR:PTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Poltreg Business Description

Address ul.Botaniczna 20, Gdansk, POL, 80-298
Poltreg SA is a biotechnology company at the clinical stage developing an innovative generation of medicines using T-regulatory cells (TREGS) in the treatment of autoimmune diseases.
46GF Score

Get the complete analysis for WAR:PTG

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł19.15
Price
zł14.20
GF Value